Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

Joanna M. Wardlaw, Eric E. Smith, Geert J. Biessels, Charlotte Cordonnier, Franz Fazekas, Richard Frayne, Richard I. Lindley, John T. O'Brien, Frederik Barkhof, Oscar R. Benavente, Sandra E. Black, Carol Brayne, Monique Breteler, Hugues Chabriat, Charles DeCarli, Frank Erik de Leeuw, Fergus Doubal, Marco Duering, Nick C. Fox, Steven GreenbergVladimir Hachinski, Ingo Kilimann, Vincent Mok, Robert van Oostenbrugge, Leonardo Pantoni, Oliver Speck, Blossom C M Stephan, Stefan Teipel, Anand Viswanathan, David Werring, Christopher Chen, Colin Smith, Mark van Buchem, Bo Norrving, Philip B. Gorelick, Martin Dichgans

Research output: Contribution to journalArticle

1409 Citations (Scopus)

Abstract

Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy. SVD can present as a stroke or cognitive decline, or can have few or no symptoms. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive deficits, physical disabilities, and other symptoms of neurodegeneration. Terminology and definitions for imaging the features of SVD vary widely, which is also true for protocols for image acquisition and image analysis. This lack of consistency hampers progress in identifying the contribution of SVD to the pathophysiology and clinical features of common neurodegenerative diseases. We are an international working group from the Centres of Excellence in Neurodegeneration. We completed a structured process to develop definitions and imaging standards for markers and consequences of SVD. We aimed to achieve the following: first, to provide a common advisory about terms and definitions for features visible on MRI; second, to suggest minimum standards for image acquisition and analysis; third, to agree on standards for scientific reporting of changes related to SVD on neuroimaging; and fourth, to review emerging imaging methods for detection and quantification of preclinical manifestations of SVD. Our findings and recommendations apply to research studies, and can be used in the clinical setting to standardise image interpretation, acquisition, and reporting. This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).

Original languageEnglish (US)
Pages (from-to)822-838
Number of pages17
JournalThe Lancet Neurology
Volume12
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Neuroimaging
Research
Neurodegenerative Diseases
Cerebral Small Vessel Diseases
Terminology
Atrophy
Blood Vessels
Stroke
Brain

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., ... Dichgans, M. (2013). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology, 12(8), 822-838. https://doi.org/10.1016/S1474-4422(13)70124-8

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. / Wardlaw, Joanna M.; Smith, Eric E.; Biessels, Geert J.; Cordonnier, Charlotte; Fazekas, Franz; Frayne, Richard; Lindley, Richard I.; O'Brien, John T.; Barkhof, Frederik; Benavente, Oscar R.; Black, Sandra E.; Brayne, Carol; Breteler, Monique; Chabriat, Hugues; DeCarli, Charles; de Leeuw, Frank Erik; Doubal, Fergus; Duering, Marco; Fox, Nick C.; Greenberg, Steven; Hachinski, Vladimir; Kilimann, Ingo; Mok, Vincent; Oostenbrugge, Robert van; Pantoni, Leonardo; Speck, Oliver; Stephan, Blossom C M; Teipel, Stefan; Viswanathan, Anand; Werring, David; Chen, Christopher; Smith, Colin; van Buchem, Mark; Norrving, Bo; Gorelick, Philip B.; Dichgans, Martin.

In: The Lancet Neurology, Vol. 12, No. 8, 08.2013, p. 822-838.

Research output: Contribution to journalArticle

Wardlaw, JM, Smith, EE, Biessels, GJ, Cordonnier, C, Fazekas, F, Frayne, R, Lindley, RI, O'Brien, JT, Barkhof, F, Benavente, OR, Black, SE, Brayne, C, Breteler, M, Chabriat, H, DeCarli, C, de Leeuw, FE, Doubal, F, Duering, M, Fox, NC, Greenberg, S, Hachinski, V, Kilimann, I, Mok, V, Oostenbrugge, RV, Pantoni, L, Speck, O, Stephan, BCM, Teipel, S, Viswanathan, A, Werring, D, Chen, C, Smith, C, van Buchem, M, Norrving, B, Gorelick, PB & Dichgans, M 2013, 'Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration', The Lancet Neurology, vol. 12, no. 8, pp. 822-838. https://doi.org/10.1016/S1474-4422(13)70124-8
Wardlaw, Joanna M. ; Smith, Eric E. ; Biessels, Geert J. ; Cordonnier, Charlotte ; Fazekas, Franz ; Frayne, Richard ; Lindley, Richard I. ; O'Brien, John T. ; Barkhof, Frederik ; Benavente, Oscar R. ; Black, Sandra E. ; Brayne, Carol ; Breteler, Monique ; Chabriat, Hugues ; DeCarli, Charles ; de Leeuw, Frank Erik ; Doubal, Fergus ; Duering, Marco ; Fox, Nick C. ; Greenberg, Steven ; Hachinski, Vladimir ; Kilimann, Ingo ; Mok, Vincent ; Oostenbrugge, Robert van ; Pantoni, Leonardo ; Speck, Oliver ; Stephan, Blossom C M ; Teipel, Stefan ; Viswanathan, Anand ; Werring, David ; Chen, Christopher ; Smith, Colin ; van Buchem, Mark ; Norrving, Bo ; Gorelick, Philip B. ; Dichgans, Martin. / Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. In: The Lancet Neurology. 2013 ; Vol. 12, No. 8. pp. 822-838.
@article{f93a7299d3b34213962c50bd0561d711,
title = "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration",
abstract = "Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy. SVD can present as a stroke or cognitive decline, or can have few or no symptoms. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive deficits, physical disabilities, and other symptoms of neurodegeneration. Terminology and definitions for imaging the features of SVD vary widely, which is also true for protocols for image acquisition and image analysis. This lack of consistency hampers progress in identifying the contribution of SVD to the pathophysiology and clinical features of common neurodegenerative diseases. We are an international working group from the Centres of Excellence in Neurodegeneration. We completed a structured process to develop definitions and imaging standards for markers and consequences of SVD. We aimed to achieve the following: first, to provide a common advisory about terms and definitions for features visible on MRI; second, to suggest minimum standards for image acquisition and analysis; third, to agree on standards for scientific reporting of changes related to SVD on neuroimaging; and fourth, to review emerging imaging methods for detection and quantification of preclinical manifestations of SVD. Our findings and recommendations apply to research studies, and can be used in the clinical setting to standardise image interpretation, acquisition, and reporting. This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).",
author = "Wardlaw, {Joanna M.} and Smith, {Eric E.} and Biessels, {Geert J.} and Charlotte Cordonnier and Franz Fazekas and Richard Frayne and Lindley, {Richard I.} and O'Brien, {John T.} and Frederik Barkhof and Benavente, {Oscar R.} and Black, {Sandra E.} and Carol Brayne and Monique Breteler and Hugues Chabriat and Charles DeCarli and {de Leeuw}, {Frank Erik} and Fergus Doubal and Marco Duering and Fox, {Nick C.} and Steven Greenberg and Vladimir Hachinski and Ingo Kilimann and Vincent Mok and Oostenbrugge, {Robert van} and Leonardo Pantoni and Oliver Speck and Stephan, {Blossom C M} and Stefan Teipel and Anand Viswanathan and David Werring and Christopher Chen and Colin Smith and {van Buchem}, Mark and Bo Norrving and Gorelick, {Philip B.} and Martin Dichgans",
year = "2013",
month = "8",
doi = "10.1016/S1474-4422(13)70124-8",
language = "English (US)",
volume = "12",
pages = "822--838",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "8",

}

TY - JOUR

T1 - Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

AU - Wardlaw, Joanna M.

AU - Smith, Eric E.

AU - Biessels, Geert J.

AU - Cordonnier, Charlotte

AU - Fazekas, Franz

AU - Frayne, Richard

AU - Lindley, Richard I.

AU - O'Brien, John T.

AU - Barkhof, Frederik

AU - Benavente, Oscar R.

AU - Black, Sandra E.

AU - Brayne, Carol

AU - Breteler, Monique

AU - Chabriat, Hugues

AU - DeCarli, Charles

AU - de Leeuw, Frank Erik

AU - Doubal, Fergus

AU - Duering, Marco

AU - Fox, Nick C.

AU - Greenberg, Steven

AU - Hachinski, Vladimir

AU - Kilimann, Ingo

AU - Mok, Vincent

AU - Oostenbrugge, Robert van

AU - Pantoni, Leonardo

AU - Speck, Oliver

AU - Stephan, Blossom C M

AU - Teipel, Stefan

AU - Viswanathan, Anand

AU - Werring, David

AU - Chen, Christopher

AU - Smith, Colin

AU - van Buchem, Mark

AU - Norrving, Bo

AU - Gorelick, Philip B.

AU - Dichgans, Martin

PY - 2013/8

Y1 - 2013/8

N2 - Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy. SVD can present as a stroke or cognitive decline, or can have few or no symptoms. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive deficits, physical disabilities, and other symptoms of neurodegeneration. Terminology and definitions for imaging the features of SVD vary widely, which is also true for protocols for image acquisition and image analysis. This lack of consistency hampers progress in identifying the contribution of SVD to the pathophysiology and clinical features of common neurodegenerative diseases. We are an international working group from the Centres of Excellence in Neurodegeneration. We completed a structured process to develop definitions and imaging standards for markers and consequences of SVD. We aimed to achieve the following: first, to provide a common advisory about terms and definitions for features visible on MRI; second, to suggest minimum standards for image acquisition and analysis; third, to agree on standards for scientific reporting of changes related to SVD on neuroimaging; and fourth, to review emerging imaging methods for detection and quantification of preclinical manifestations of SVD. Our findings and recommendations apply to research studies, and can be used in the clinical setting to standardise image interpretation, acquisition, and reporting. This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).

AB - Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy. SVD can present as a stroke or cognitive decline, or can have few or no symptoms. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive deficits, physical disabilities, and other symptoms of neurodegeneration. Terminology and definitions for imaging the features of SVD vary widely, which is also true for protocols for image acquisition and image analysis. This lack of consistency hampers progress in identifying the contribution of SVD to the pathophysiology and clinical features of common neurodegenerative diseases. We are an international working group from the Centres of Excellence in Neurodegeneration. We completed a structured process to develop definitions and imaging standards for markers and consequences of SVD. We aimed to achieve the following: first, to provide a common advisory about terms and definitions for features visible on MRI; second, to suggest minimum standards for image acquisition and analysis; third, to agree on standards for scientific reporting of changes related to SVD on neuroimaging; and fourth, to review emerging imaging methods for detection and quantification of preclinical manifestations of SVD. Our findings and recommendations apply to research studies, and can be used in the clinical setting to standardise image interpretation, acquisition, and reporting. This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).

UR - http://www.scopus.com/inward/record.url?scp=84880391350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880391350&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(13)70124-8

DO - 10.1016/S1474-4422(13)70124-8

M3 - Article

C2 - 23867200

AN - SCOPUS:84880391350

VL - 12

SP - 822

EP - 838

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 8

ER -